10:20 AM EST - Sunniva Inc. : And CannaPharmaRx have entered into a share purchase agreement dated June 11, pursuant to which Sunniva has agreed to sell Sunniva Medical Inc. to CannaPharmaRx in an all-cash transaction for $20 million less certain outstanding liabilities in SMI, including the mortgage on the property. Net proceeds payable to Sunniva are anticipated to be approximately $15.5 million. Closing is anticipated to occur on or around July 5. Effectiveness of the agreement is subject to certain closing conditions including completion of a financial audit of SMI and receipt of sufficient financing by the Purchaser. Sunniva Inc.
shares CSE:SNN are trading up $0.08 at $3.23.
